6505-01-657-1391 Sodium nitroprusside
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 18, 2026
- Last price paid
- …
- Standard price
- $191.19 per VI
- DLA's catalog price, not a price paid
- Approved sources
- 2
- Awards on record
- 98
- 2017 to 2026
- DLA demand
- –
Identification
- Item name
- Sodium nitroprusside
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 01-AUG-16
- Unit
- VI
- NSN
- 6505-01-657-1391
- NIIN
- 01-657-1391
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| SAGENT PHARMACEUTICALS, INC | 4RP13 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC25021-0310-02 | DLA approved-source file |
| MEDICURE PHARMA INC | 5EAC9 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC25208-0003-05 | DLA approved-source file |
| 5JU90 | A (Active) | 3 (Design control reference) / 9 (Was the design control reference) | NDC14789-0012-02 | FLIS part list | |
| 64616 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 6505NCM162947 | FLIS part list | |
| 89875 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 1404052 | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
2 contracts DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX25D8022 | CARDINAL HEALTH, INC. | SPE2DX | $76,117,432 | March 6, 2035 | INDEFINITE DELIVERY / REQUIREMENTS | No | 1 | August 10, 2026 |
| SPE2DX15D9383 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $4,999,999 | December 31, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 24 | April 5, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909220 (Crdiovsclr med,cont amiodarone,its salts,dses/pkg)
- PINC
- 0066689
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | VI | $150.28 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | VI | $150.28 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | VI | $150.28 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | VI | $191.19 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0336DIBBS only | 6505-01-657-1391 | Sodium nitroprusside | 20 | VI | $191.19 per VI | … | … | No set-aside | No | November 12, 2026 | November 18, 20265 days left |
→ These RFQs in the DIBBS list
Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 78 days, production 113 days (191 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
98 award lines since 2017, 9 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 0AG09SZY HOLDINGS, LLC | 42 | June 24, 2026 |
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 32 | September 17, 2020 |
| 49KA0ASE DIRECT, INC. | 7 | August 30, 2023 |
| 9CBT7MED STOP PHARMACEUTICALS INC. | 5 | January 15, 2025 |
| 6UV66MIDWEST PHARMACEUTICALS INC | 5 | February 17, 2023 |
| 3W8H0MR UNLIMITED, LLC | 3 | January 5, 2026 |
| 1KA59ARS SALES & SERVICES LLC | 2 | April 16, 2021 |
| 00E55Cardinal Health, Inc. | 1 | August 10, 2026 |
| 0NUS8HENRY SCHEIN, INC. | 1 | June 22, 2022 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 4 | 3 |
| 2025 | 14 | 3 |
| 2024 | 15 | 2 |
| 2023 | 13 | 3 |
| 2022 | 10 | 4 |
| 2021 | 10 | 3 |
| 2020 | 1 | 1 |
| 2018 | 28 | 1 |
| 2017 | 3 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | SZY HOLDINGS, LLC | $25,499 | 42 |
| 2 | DMS PHARMACEUTICAL GROUP INC | $6,974 | 32 |
| 3 | ASE DIRECT, INC. | $5,897 | 7 |
| 4 | MED STOP PHARMACEUTICALS INC. | $3,404 | 5 |
| 5 | MIDWEST PHARMACEUTICALS INC | $1,758 | 5 |
| 6 | MR UNLIMITED, LLC | $1,014 | 3 |
| 7 | ARS SALES & SERVICES LLC | $1,000 | 2 |
| 8 | HENRY SCHEIN, INC. | $841 | 1 |
| 9 | CARDINAL HEALTH, INC. | $92 | 1 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2D926F8162From the item's award history | August 10, 2026 | CARDINAL HEALTH, INC. | $92 |
| SPE2DP26P0950From the item's award history | June 24, 2026 | SZY HOLDINGS, LLC | $495 |
| SPE2DP26P0945From the item's award history | June 18, 2026 | SZY HOLDINGS, LLC | $297 |
| SPE2DP26V0292From the item's award history | January 5, 2026 | MR UNLIMITED, LLC | $102 |
| SPE2DP26V0243From the item's award history | December 15, 2025 | MR UNLIMITED, LLC | $203 |
| SPE2DP25V3650From the item's award history | September 10, 2025 | SZY HOLDINGS, LLC | $104 |
| SPE2DP25V3451From the item's award history | August 22, 2025 | SZY HOLDINGS, LLC | $303 |
| SPE2DP25V3214From the item's award history | August 4, 2025 | MR UNLIMITED, LLC | $709 |
| SPE2DP25V2793From the item's award history | July 7, 2025 | SZY HOLDINGS, LLC | $2,900 |
| SPE2DP25V2760From the item's award history | July 2, 2025 | SZY HOLDINGS, LLC | $106 |
| SPE2DP25V2425From the item's award history | June 9, 2025 | SZY HOLDINGS, LLC | $205 |
| SPE2DP25V1948From the item's award history | May 5, 2025 | SZY HOLDINGS, LLC | $496 |
| SPE2DP25V1802From the item's award history | April 21, 2025 | SZY HOLDINGS, LLC | $886 |
| SPE2DP25V1660From the item's award history | April 7, 2025 | SZY HOLDINGS, LLC | $796 |
| SPE2DP25V1615From the item's award history | April 3, 2025 | SZY HOLDINGS, LLC | $300 |
| SPE2DP25V1444From the item's award history | March 20, 2025 | SZY HOLDINGS, LLC | $302 |
| SPE2DP25V0722From the item's award history | January 15, 2025 | MED STOP PHARMACEUTICALS INC. | $204 |
| SPE2DP25V0698From the item's award history | January 13, 2025 | SZY HOLDINGS, LLC | $106 |
| SPE2DP25V0623From the item's award history | December 30, 2024 | SZY HOLDINGS, LLC | $2,575 |
| SPE2DP24V2439From the item's award history | August 29, 2024 | MED STOP PHARMACEUTICALS INC. | $534 |
| SPE2DP24V2356From the item's award history | August 22, 2024 | MED STOP PHARMACEUTICALS INC. | $1,390 |
| SPE2DP24V2377From the item's award history | August 22, 2024 | MED STOP PHARMACEUTICALS INC. | $321 |
| SPE2DP24V2239From the item's award history | August 13, 2024 | SZY HOLDINGS, LLC | $536 |
| SPE2DP24V2110From the item's award history | August 2, 2024 | SZY HOLDINGS, LLC | $342 |
| SPE2DP24V1922From the item's award history | July 15, 2024 | MED STOP PHARMACEUTICALS INC. | $956 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.